Genomics analytics platform developer Sophia Genetics has gone public ten years after it was co-founded by researchers from EMBL, Stanford and University of Geneva

Sophia Genetics, a Switzerland-based genomics analytics platform operator co-founded by researchers from EMBL, Stanford University and University of Geneva, has amassed $234m in an initial public offering.

Sophia priced 13 million shares at $18 per share, the midpoint of its initial $17 to $19m price range. The shares are currently priced at $19.48 at the time of publication, which suggests a market capitalisation of $1.2bn.

Sophia operates a cloud-based software-as-a-service platform used by medical professionals to extract insights from complex…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?